Clinical trial
BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
NCT06018818 is registered in ClinicalTrials.gov with Biotronik SE & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
- Lead sponsor
- Biotronik SE & Co. KG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 23, 2023
- Completion date
- July 21, 2025
- Enrollment
- 129 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.